Asthma, a disease characterized by bronchial hyperreactivity to various physical, chemical, nd pharmacological stimuli, has been extensively studied, and many pathogenic hypotheses have been evoked. Theories attempting to explain the development of the asthmatic syndrome are still fragmentary: the parasympathetic system appears to be the predominant factor involved in changes in nervous system regulatory alterations, this hypothesis being suggested to explain the bronchial hyperreactivity occurring after viral infections or exposure to certain oxidizing agents. The results of morphological and ultrastructural studies of human bronchial muscle suggest the involvement of modifications in a non-adrenergic relaxant system, analogous to the purinergic system in the digestive tract, but supply marked evidence of changes in sympathetic innervation. An alteration in the smooth muscle itself may be implicated: muscle hyperplasia, increase in contractility, and especially modification in pharmacological receptors situated on the membrane of smooth muscle fibres : acquired or spontaneous blocking of beta receptors, activation of alpha receptors, and alteration of cholinergic receptors. The chemical theory suggests that bronchoconstriction is due to local excess of mediators from cells taking part in the allergic and inflammatory reactions, and which are found in the tracheobronchial tree. The possible relationships between repeated secretion of mediators in allergic subjects and the bronchial hyperreactivity to numerous non-specific stimuli appear to be a complex subject. The possibility that a single biochemical anomaly is involved in asthma has been raised, but further basic research is necessary to explain the alterations in biochemical processes involved in such different phenomena as muscle contraction, secretion of anaphylactic mediators, and nerve impulse transmission.

Download full-text PDF

Source

Publication Analysis

Top Keywords

bronchial hyperreactivity
12
smooth muscle
8
bronchial
5
muscle
5
[physiopathological mechanisms
4
mechanisms asthma
4
asthma bronchial
4
bronchial hyperreactivity]
4
hyperreactivity] asthma
4
asthma disease
4

Similar Publications

While progress has been made in recent years, there are still no suitable and accepted , or models that can be used to accurately predict whether a chemical substance has the intrinsic property to cause immune-mediated chemical respiratory allergy, typically manifested as allergic asthma or allergic rhinitis which represents a severe health hazard. Regulatory authorities have relied primarily on clinical evidence (case reports, clinical databases, worker exposure studies) to classify substances as respiratory sensitizers, but this evidence can lack a proven immunological mechanism which is necessary to identify substances which can cause life-long sensitization and clinically relevant allergic symptoms in the respiratory tract in an exposed population (such respiratory allergens may be considered as "true" sensitizers, in analogy to the definition of skin sensitization, and in contrast to respiratory irritants). In light of this, the European Center for Ecotoxicology and Toxicology of Chemicals convened a Task Force to evaluate the types of clinical methods and data sources and the implications of relying on such data for regulatory decision making from a scientific perspective.

View Article and Find Full Text PDF

Background: Some studies have suggested that the forced expiratory flow between 25 and 75% of vital capacity (FEF) can be used as an early marker of bronchial hyperresponsiveness (BHR) in asthma and allergic rhinitis (AR), but is highly variable. Here, we aimed to assess whether the FEF can be used to diagnose BHR in patients with asthma-like symptoms and AR.

Methods: PubMed, EMBASE, Web of Science, Wiley Online Library, Cochrane Library, SinoMed, CNKI, and Wanfang Data were searched to acquire eligible studies.

View Article and Find Full Text PDF

Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review.

Curr Issues Mol Biol

December 2024

Molecular Biology Laboratory, Department of Research in Pulmonary Fibrosis, National Institute of Respiratory Diseases "Ismael Cosío Villegas", Calzada de Tlalpan 4502, Col. Sección XVI, Mexico City 14080, Mexico.

Idiopathic pulmonary fibrosis (IPF) is a chronic, deathly disease with no recognized effective cure as yet. Furthermore, its diagnosis and differentiation from other diffuse interstitial diseases remain a challenge. Circulating miRNAs have been measured in IPF and have proven to be an adequate option as biomarkers for this disease.

View Article and Find Full Text PDF

Objective: to determine the distribution of genotypes of genetic polymorphism of manganese superoxide dismutaseand to assess the ventilation lung capacity in children- residents of radioactively contaminated areas and childrenexposed to stressful life events during the war period.

Materials And Methods: The study involved school-age children - residents of radioactively contaminated areas(RCA) and children exposed to stressful life events during wartime. All those examined had no clinical signs of respiratory pathology.

View Article and Find Full Text PDF

Changing paradigms in asthma management.

Am J Med Sci

December 2024

Division of Clinical Immunology, The University of Mississippi Medical Center, Jackson, MS, USA. Electronic address:

Asthma is a complex clinical syndrome characterized by airway inflammation that can cause variable, usually reversible airway obstruction and bronchial hyperreactivity. This illness has a spectrum from intermittent to persistent that has mild, medium or severe intensity. As our understanding of the underling inflammatory pathway grows, so too does our catalogue of advanced treatments (such as monoclonal antibodies), opening the path for treatment individually curated for patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!